Modulation of Antibody Responses by Conjugates of Antigens with Monomethoxypolyethylene Glycol

  • Alec H. Sehon


The use of tolerogenic conjugates of monomethoxypolyethylene glycol (mPEG) and diverse antigens, including xenogeneic monoclonal immunoglobulins, is reviewed with respect to the induction of specific abrogation of antibody responses. Evidence is presented for activation of specific suppressor T (Ts) cells by antigen-mPEG conjugates and for the release of suppressor lymphokines (TsFs) from these cells; both Ts cells and TsFs are able to suppress antigen-specific immune responses on transfer to syngeneic mice. The therapeutic potential of tolerogenic mPEG conjugates is discussed with respect to IgE-mediated allergies and diseases which could be ameliorated by administration of xenogeneic monoclonal antibodies and of their respective immunotoxins, as would be the case for suppression of rejection of organ transplants, localization and destruction of tumors, and in vivo annihilation of the human immunodeficiency virus (HIV).


Human Immunodeficiency Virus Naive Mouse Severe Combine Immunodeficiency Disease Adenosine Deaminase Deficiency Reaginic Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abuchowski, A., 1976, Effect of covalently attached polyethylene glycol on the immunogenicity and activity of enzymes; Ph.D. Dissertation, Rutgers Univ., New Brunswick, N.J.Google Scholar
  2. Abuchowski, A., Kazo, G.M., Verhoest, C.R., Van Es, T., Kafke Witz, D., Nucci, M.L., Viau, A.T., and Davis, F.F., 1984, Cancer therapy with chemically modified enzymes. I. Anti-tumor properties of polyethylene glycol-asparaginase conjugates, Cancer Biochem. Biophys., 7:175.PubMedGoogle Scholar
  3. Athota, R. and Sehon A.H. (unpublished data).Google Scholar
  4. Benjamin, R.J. and Waldmann, H., 1986, Induction of tolerance by monoclonal antibody therapy, Nature, 320:449.PubMedCrossRefGoogle Scholar
  5. Brüggemann, M., Williams, G.T., Bindon, C.I., Clark, M.R., Walker, M.R., Jefferis, R., Waldmann, H., and Neuberger, M.S., 1987, Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies, J. Exp. Med., 166:1351.PubMedCrossRefGoogle Scholar
  6. Dillman, R.O., 1985, Monoclonal antibodies in the treatment of cancer, CRC Crit. Rev. Oncol. Hematol., 1:357.CrossRefGoogle Scholar
  7. Dreborg, S., and Akerblom, E., Immunotherapy with polyethylene glycol modified allergens, CRC Crit. Rev. Therapeutic Drug Carrier Systems, (in press).Google Scholar
  8. Dresser, D.W., 1961, Acquired immunological tolerance to a fraction of bovine gamma globulin, Immunology, 4:13.PubMedGoogle Scholar
  9. Frankel, A.E., 1988, “Immunotoxins,” Kluwer Academic Publishers, Boston.CrossRefGoogle Scholar
  10. Fung, M.S.C., Sun, C., and Sun, N-C., 1987, Monoclonal antibodies that neutralize HIV-1 virions and inhibit syncytium formation by infected cells, Biotechnol., 5:940.CrossRefGoogle Scholar
  11. Hatton, T.W., Ekramoddoullah, A.K.M., Kisil, F.T., Sehon, A.H., and Hill, R.D., 1989, Identification of cDNA clones representing Group I pollen allergens from Kentucky Bluegrass, in: Advances in the Biosciences, Vol. 74, “Allergy and Molecular Biology”, A.S. El Shami and T.G. Merrett, eds., Pergamon Press, New York.Google Scholar
  12. Hershfield, M.S., Buckley, R.H., Greenberg, M.L., Melton, A.L., Schiff, R., Hatem, C., Kurtzberg, J., Markert, M.L., Kobayashi, R.H., Kobayashi, A.L., and Abuchowski, A., 1987, Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase, N. Eng. J. Med., 316:589.CrossRefGoogle Scholar
  13. Ho, D.D., Kaplan, J.C., Rackauskas, I.E., and Gurney, M.E., 1988, Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization, Science, 239:1021.PubMedCrossRefGoogle Scholar
  14. Jonker, M. and DenBrok, J.H.A.M., 1987, Idiotype switching of CD4-specific monoclonal antibodies can prolong therapeutic effectiveness in spite of host anti-mouse IgG antibodies, Eur. J. Immunol., 17:1547.PubMedCrossRefGoogle Scholar
  15. Lee, W.Y. and Sehon, A.H., 1977, Abrogation of reaginic antibodies with modified allergens, Nature, London, 267:618.CrossRefGoogle Scholar
  16. Lee, W.Y. and Sehon, A.H., 1978, Suppression of reaginic antibodies with modified allergens. II. Abrogation of reaginic antibodies with allergens conjugated to polyethylene glycol, Int. Archs. Allergy appl. Immun., 56:196.Google Scholar
  17. Lyerly, H.K., Matthews, T.J., Langlois, A.J., Bolognesi, D.P., and Weinhold, K.J., 1987, Human T-cell lymphotropic virus IIIb glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack, Proc. Natl. Acad. Sci., 84:4601.PubMedCrossRefGoogle Scholar
  18. Maiti, P.K., Lang, G.M., and Sehon, A.H., 1988, Tolerogenic conjugates of xenogeneic monoclonal antibodies with monomethoxypolyethylene glycol: I. Induction of long-lasting tolerance to xenogeneic monoclonal antibodies, Int. J. Cancer, Supplement 3:17.CrossRefGoogle Scholar
  19. Müller, U., Lanner, A., Schmid, P., Bischof, M., Dreborg, S., and Hoigné, R., 1985, A double-blind study on immunotherapy with chemically modified honey bee venom: Monomethoxypolyethylene glycol-coupled versus crude honey bee venom, Int. Arch. Allergy appl. Immunol, 77:201.PubMedCrossRefGoogle Scholar
  20. Ortho Multicenter Transplant Study Group, 1985, A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplant, N. Engl. J. Med., 313:337.CrossRefGoogle Scholar
  21. Riechmann, L., Clark, M., Waldmann, H., and Winter, G., 1988, Reshaping human antibodies for therapy, Nature London, 332:323.PubMedCrossRefGoogle Scholar
  22. Savoca, K.V., Davis, F.F., and Palczuk, N.C., 1984, Induction of toler- ance in mice by uricase and monomethoxypolyethylene glycol-modified uricase, Int. Arch. Allergy appl. Immunol., 75: 58.PubMedCrossRefGoogle Scholar
  23. Schon, A.H., 1982, Suppression of IgE antibody responses with tolero- genic conjugates of allergens and haptens, Progr. Allergy, 32:161.Google Scholar
  24. Sehon, A.H., 1986, Potential use of allergens modified with monometho- xypolyethylene glycol for immunotherapy of atopic patients, in Proc. XII Int. Congr. Allergol. and Clin. Immunol., The C.V. Mosby Company, St. Louis.Google Scholar
  25. Sehon, A.H., 1988, Could Immunological Strategies for Cancer Treatment be Adapted for AIDS?, Clin. Immunol. Newsletter, 9:77.CrossRefGoogle Scholar
  26. Sehon, A.H., Lang, G.M., and Carter, B.G., 1983, Further insights into the mechanism underlying the downregulation of IgE antibodies by conjugates of allergens with monomethoxypolyethylene glycols (mPEGs). in: Proc. XIth Int. Cong. Allergol. and Clin. Immunol., J.W. Kerr and M.A. Ganderton, eds., McMillan, London.Google Scholar
  27. Sehon, A.H. and Lang, G.M., 1986, The use of nonionic, water soluble polymers for the synthesis of tolerogenic conjugates of antigens, in: “Mediators of Immune Regulation and Immunotherapy”, S.K. Singal and T.L. Delovitch eds., Elsevier, New York.Google Scholar
  28. Steele, J.K., Stammers, A.T., Chan, A., and Levy, J., 1986, Characterization of an anti-idiotypic T cell hybridoma involved in the regulation of the immune response to the P815 mastocytoma, J. Immunol., 137:3550.PubMedGoogle Scholar
  29. Weigle, W., 1973, Immunological unresponsiveness, Advances in Immunology, 16:61.PubMedCrossRefGoogle Scholar
  30. Wilkinson, I., Jackson, C-J.C., Lang, G.M., Holford-Strevens, V., and Sehon, A.H., 1987, Tolerance induction in mice by conjugates of monoclonal immunoglobulins and monomethoxypolyethylene glycol. Transfer of tolerance by T cells and by T cell extracts, J. Immunol., 139:326.PubMedGoogle Scholar
  31. Wilkinson, I., 1988, Tolerogenic monomethoxypolyethylene glycol derivatives of xenogeneic monoclonal immunoglobulins. Ph.D. Dissertation, The University of Manitoba.Google Scholar
  32. Zimmer. A M Goldman-Lieken R E and Kazikiew J M 1987 Radioimmunotherapy retreatment of cutaneous T cell lymphoma: effect of plasmapheres is on human antimurine antibody titers, J. Nucl. Med., 28:603.Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Alec H. Sehon
    • 1
  1. 1.MRC Group for Allergy Research Department of Immunology Faculty of MedicineThe University of ManitobaWinnipegCanada

Personalised recommendations